| [Flash Point] 166 | |
| [Fire Fighting] Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Extinguishing media: Use agent most appropriate to extinguish fire. | |
| [Ingestion] If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never give anything by mouth to an unconscious person. Get medical aid immediately. | |
| [Inhalation] Get medical aid immediately. Remove from exposure to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. | |
| [Skin] Get medical aid. Flush skin with plenty of soap and water for at least 15 minutes while removing contaminated clothing and shoes. | |
| [Eyes] Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately. | |
| [Storage] Store in a cool, dry place. Keep container closed when not in use. | |
| [Handling] Wash thoroughly after handling. Use only in a well ventilated area. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation. | |
| [Inhalation] May cause respiratory tract irritation. May cause adverse central nervous system effects including headache, convulsions, and possible death. | |
| [Skin] May cause skin irritation. | |
| [Eyes] May cause eye irritation. | |
| [Ingestion] Harmful if swallowed. May cause gastrointestinal irritation with nausea, vomiting and diarrhea. May cause central nervous system effects. May cause headache, nausea, fatigue, and dizziness. | |
| [Personal Protection] Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166. Skin: Wear appropriate protective gloves to prevent skin exposure. Clothing: Wear appropriate protective clothing to prevent skin exposure. | |
| [Respirators] Follow the OSHA respirator regulations found in 29CFR 1910.134 or European Standard EN 149. Always use a NIOSH or European Standard EN 149 approved respirator when necessary. | |
| [Exposure Effects] Generalized depression of vital signs may follow a period of transient physiological stimulation. CNS effects invariably precede significant cardiovascular toxicity, except following massive iv injection. | |
| [Appearance] White to yellow powder with a characteristic odor. | |
| [Solubility in water] Slightly soluble | |
| [Melting Point] 70 | |
| [Boiling Point] 351 | |
| [Vapor Pressure] 4E-5 (25 C) | |
| [Density] 1.04 g/cm3 | |
| [pKa/pKb] 5.47 (pKb) | |
| [Partition Coefficient] 2.36 | |
| [Heat Of Vaporization] 59.7 kJ/mol | |
| [Usage] Medication. | |
| [Product Name] Xylocaine | |
| [Synonyms] 2-(Diethylamino)-2',6'-acetoxylidide alpha-diethylamino-2,6-dimethylacetanilide alpha-Diethylaminoaceto-2,6-xylidide Anestacon Diethylaminoacet-2,6-xylidide Diethylaminoaceto-2,6-xylidide | |
| [CAS] "CASEN_137-58-6.htm">137-58-6 | |
| [Formula] C14H22N2O | |
| [Molecular Weight] 234.34 | |
| [EINECS] 205-302-8 | |
| [RTECS] AN7525000 | |
| [RTECS Class] Drug; Mutagen; Reproductive Effector; Human Data | |
| [Merck] 12,5505 | |
| [Beilstein/Gmelin] 2215784 | |
| [Beilstein Reference] 4-12-00-02538 | |
| [Small spills/leaks] Sweep up or absorb material, then place into a suitable clean, dry, closed container for disposal. | |
| [Stability] Stable under normal temperatures and pressures. | |
| [Incompatibilities] Strong oxidants. | |
| [Decomposition] Nitrogen oxides, carbon monoxide, carbon dioxide. |
Print